Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Viveve Medical Inc (VIVE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6586
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, OAB and bladder leakage, and female sexual problems. It provides Geneveve treatment which uses clinically-proven cryogen-cooled monopolar radiofrequency (CMRF) to deliver gentle volumetric heating while cooling delicate surface tissue. Viveve Medical’s Geneveve treatment also stimulates the body’s natural collagen formation process. The company has its distribution networks in the Middle East, Asia Pacific, Europe, North America and Latin America. It operates its office in Sunnyvale, the US. Viveve Medical is headquartered in Englewood, Colorado, the US.

Viveve Medical Inc (VIVE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Viveve Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Viveve Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Viveve Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Viveve Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Viveve Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Viveve Medical Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Viveve Secures USD5 Million from Square 1 Bank 11
Viveve Secures Venture Funding 12
Partnerships 13
Viveve Medical Enters into Distribution Agreement with InControl Medical 13
Equity Offering 14
Viveve Medical Raises USD34.5 Million in Public Offering of Shares 14
Viveve Medical to Raise up to USD25 Million in Public Offering of Shares 16
Viveve Medical Invests USD2.5 Million in InControl Medical 17
Viveve Medical Raises USD34.5 Million in Public Offering of Shares 18
Viveve Medical Raises USD15.5 Million in Public Offering of Shares 20
Viveve Medical to Raise USD6 Million in Private Placement of Shares 21
Viveve Medical Raises USD12 Million in Private Placement of Shares 22
Viveve Raises USD4.5 Million in Private Placement of Common Stock 23
PLC Systems Completes Private Placement Of Shares For US$1.75 Million 24
PLC Systems Completes Private Placement Of Common Stock For US$4 Million 25
Debt Offering 26
Plc Systems Completes Private Placement Of Notes Due 2016 For US$0.25 Million 26
PLC Systems Completes Second Tranche of Private Placement Of 5% Senior Notes For US$1 Million 27
Acquisition 29
PLC Systems Acquires Viveve, Women’s Healthcare Technology Provider 29
Viveve Medical Inc – Key Competitors 30
Viveve Medical Inc – Key Employees 31
Viveve Medical Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Strategy And Business Planning 33
Feb 03, 2017: Viveve Announces Relocation of Corporate Headquarters to Denver, Colorado 33
Financial Announcements 34
Aug 09, 2018: Viveve reports second quarter 2018 financial results and provides corporate update 34
Jul 10, 2018: Viveve Reports Preliminary Second Quarter 2018 Revenue of $5.5 million 35
May 10, 2018: Viveve Reports First Quarter 2018 Financial Results 36
Mar 15, 2018: Viveve Reports Fourth Quarter and Full Year 2017 Financial Results 37
Jan 04, 2018: Viveve Announces Preliminary 2017 Fourth Quarter and Year-End Financial Results and Provides 2018 Revenue Guidance 39
Oct 18, 2017: Viveve Releases Preliminary Third Quarter 2017 Financial Results 40
Aug 10, 2017: Viveve Announces Second Quarter 2017 Financial Results and Strategic Partnership with InControl Medical 41
May 11, 2017: Viveve Reports First Quarter 2017 Financial Results 43
Feb 16, 2017: Viveve Reports Fourth Quarter and Full Year 2016 Financial Results 44
Corporate Communications 46
Sep 13, 2018: Viveve Medical names Steve Basta and Karen Zaderej as new independent board members 46
May 10, 2018: Viveve Appoints Scott Durbin as Chief Executive Officer 47
Jan 31, 2017: Viveve Names Dr. Grant Stevens Chairman of Aesthetic Advisory Board 48
Legal and Regulatory 49
Jun 04, 2018: Viveve Announces Settlement of Patent Infringement Litigation with Thermi 49
Product News 50
Aug 14, 2018: Viveve Initiates LIBERATE-international trial for improvement of stress urinary incontinence 50
Jun 04, 2018: Viveve Announces Settlement of Patent Infringement Litigation with Thermi 51
Oct 30, 2017: Viveve Launches GENEVEVE by Viveve Treatment in Canada 52
Apr 25, 2017: US District Court Denies Thermi’s Motions to Dismiss Viveve Patent Infringement Suit 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Viveve Medical Inc, Medical Equipment, Key Facts, 2017 2
Viveve Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Viveve Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Viveve Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Viveve Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Viveve Medical Inc, Deals By Market, 2012 to YTD 2018 9
Viveve Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Viveve Secures USD5 Million from Square 1 Bank 11
Viveve Secures Venture Funding 12
Viveve Medical Enters into Distribution Agreement with InControl Medical 13
Viveve Medical Raises USD34.5 Million in Public Offering of Shares 14
Viveve Medical to Raise up to USD25 Million in Public Offering of Shares 16
Viveve Medical Invests USD2.5 Million in InControl Medical 17
Viveve Medical Raises USD34.5 Million in Public Offering of Shares 18
Viveve Medical Raises USD15.5 Million in Public Offering of Shares 20
Viveve Medical to Raise USD6 Million in Private Placement of Shares 21
Viveve Medical Raises USD12 Million in Private Placement of Shares 22
Viveve Raises USD4.5 Million in Private Placement of Common Stock 23
PLC Systems Completes Private Placement Of Shares For US$1.75 Million 24
PLC Systems Completes Private Placement Of Common Stock For US$4 Million 25
Plc Systems Completes Private Placement Of Notes Due 2016 For US$0.25 Million 26
PLC Systems Completes Second Tranche of Private Placement Of 5% Senior Notes For US$1 Million 27
PLC Systems Acquires Viveve, Women's Healthcare Technology Provider 29
Viveve Medical Inc, Key Competitors 30
Viveve Medical Inc, Key Employees 31
Viveve Medical Inc, Other Locations 32
Viveve Medical Inc, Subsidiaries 32

List of Figures
Viveve Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Viveve Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Viveve Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Viveve Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Viveve Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Viveve Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Viveve Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Estchem Co Ltd:企業の戦略的SWOT分析
    Estchem Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Pentair plc (PNR)-エネルギー分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • Simpson Manufacturing Co Inc (SSD):企業の財務・戦略的SWOT分析
    Simpson Manufacturing Co Inc (SSD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • ArjoHuntleigh AB-医療機器分野:企業M&A・提携分析
    Summary ArjoHuntleigh AB (ArjoHuntleigh), a subsidiary of Getinge AB is a medical device company that offers hospital equipment. The company provides integrated solutions to help people affected by reduced mobility and make them self-sufficient. Its products include disinfection and hygiene systems, …
  • Vedanta Ltd:企業のM&A・事業提携・投資動向
    Vedanta Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • St. Joseph Health:企業の戦略的SWOT分析
    St. Joseph Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sears Holdings Corporation (SHLD):企業の財務・戦略的SWOT分析
    Sears Holdings Corporation (SHLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • GWA Group Ltd (GWA):企業の財務・戦略的SWOT分析
    GWA Group Ltd (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • AltaGas Ltd.:企業のM&A・事業提携・投資動向
    AltaGas Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AltaGas Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Dauntless Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Dauntless Pharmaceuticals Inc (Dauntless) is a biotech company that develops therapeutic agents. The company’s pipeline product include DP1038, a therapeutic agent used for the treatment of endocrine cancers. It operates through various stages of development. Dauntless manages the developmen …
  • Elcelyx Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Elcelyx Therapeutics Inc (Elcelyx) is a developer of novel therapies for the treatment of type 2 diabetes, kidney disease and limb amputation. The company develops drugs that regulate the gut neuroendocrine system including the L-cell, which assists in the release of glucoregulatory hormones …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • PT XL Axiata Tbk (EXCL):企業の財務・戦略的SWOT分析
    PT XL Axiata Tbk (EXCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • Shima Seiki Mfg Ltd (6222):企業の財務・戦略的SWOT分析
    Shima Seiki Mfg Ltd (6222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆